1: Tsai MC, Wu J, Kupfer S, Vakilynejad M. Population Pharmacokinetics and
Exposure-Response of a Fixed-Dose Combination of Azilsartan Medoxomil and
Chlorthalidone in Patients with Stage 2 Hypertension. J Clin Pharmacol. 2015 Dec
3. doi: 10.1002/jcph.684. [Epub ahead of print] PubMed PMID: 26632101.
2: Castro-Torres Y, Fleites-Pérez A, Carmona-Puerta R, Jiménez-Garrido RG.
Negative effects of chlorthalidone on sympathetic nervous system and insulin
resistance in hypertensive patients may be avoided with spironolactone: further
studies are still needed. Ir J Med Sci. 2015 Dec;184(4):727-9. doi:
10.1007/s11845-015-1350-1. Epub 2015 Sep 4. PubMed PMID: 26341505.
3: Cooney D, Milfred-LaForest S, Rahman M. Diuretics for hypertension:
Hydrochlorothiazide or chlorthalidone? Cleve Clin J Med. 2015 Aug;82(8):527-33.
doi: 10.3949/ccjm.82a.14091. Review. PubMed PMID: 26270432.
4: Shah JV, Patel DP, Shah PA, Sanyal M, Shrivastav PS. Simultaneous
quantification of atenolol and chlorthalidone in human plasma by
ultra-performance liquid chromatography-tandem mass spectrometry. Biomed
Chromatogr. 2015 Jun 10. doi: 10.1002/bmc.3537. [Epub ahead of print] PubMed
PMID: 26096961.
5: Ramakrishna R, Puttrevu SK, Bhateria M, Bala V, Sharma VL, Bhatta RS.
Simultaneous determination of azilsartan and chlorthalidone in rat and human
plasma by liquid chromatography-electrospray tandem mass spectrometry. J
Chromatogr B Analyt Technol Biomed Life Sci. 2015 May 15;990:185-97. doi:
10.1016/j.jchromb.2015.03.018. Epub 2015 Mar 28. PubMed PMID: 25899870.
6: Roush GC, Ernst ME, Kostis JB, Tandon S, Sica DA. Head-to-head comparisons of
hydrochlorothiazide with indapamide and chlorthalidone: antihypertensive and
metabolic effects. Hypertension. 2015 May;65(5):1041-6. doi:
10.1161/HYPERTENSIONAHA.114.05021. Epub 2015 Mar 2. Review. PubMed PMID:
25733245.
7: Sirisha T, Gurupadayya B, Siddiraju S. Optimized and Validated RP-UPLC Method
for the Determination of Losartan Potassium and Chlorthalidone in Pharmaceutical
Formulations. Adv Pharm Bull. 2015 Mar;5(1):133-6. doi: 10.5681/apb.2015.019.
Epub 2015 Mar 5. PubMed PMID: 25789231; PubMed Central PMCID: PMC4352217.
8: Kipnes MS, Handley A, Lloyd E, Barger B, Roberts A. Safety, tolerability, and
efficacy of azilsartan medoxomil with or without chlorthalidone during and after
8 months of treatment for hypertension. J Clin Hypertens (Greenwich). 2015
Mar;17(3):183-92. doi: 10.1111/jch.12474. Epub 2015 Jan 24. PubMed PMID:
25619410.
9: Heise CW, Beutler D, Bosak A, Orme G, Loli A, Graeme K. Massive Atenolol,
Lisinopril, and Chlorthalidone Overdose Treated with Endoscopic Decontamination,
Hemodialysis, Impella Percutaneous Left Ventricular Assist Device, and ECMO. J
Med Toxicol. 2015 Mar;11(1):110-4. doi: 10.1007/s13181-014-0419-y. PubMed PMID:
25146229; PubMed Central PMCID: PMC4371031.
10: Roush GC, Ernst ME, Kostis JB, Kaur R, Sica DA. Not just chlorthalidone:
evidence-based, single tablet, diuretic alternatives to hydrochlorothiazide for
hypertension. Curr Hypertens Rep. 2015 Apr;17(4):540. doi:
10.1007/s11906-015-0540-6. PubMed PMID: 25821163.
11: DiNicolantonio JJ, Bhutani J, Lavie CJ, O'Keefe JH. Evidence-based diuretics:
focus on chlorthalidone and indapamide. Future Cardiol. 2015 Mar;11(2):203-17.
doi: 10.2217/fca.14.83. Review. PubMed PMID: 25760879.
12: Singer JR, Pearce ZD, Westhouse SJ, Siebert KJ. Uveal effusion as a mechanism
of bilateral angle-closure glaucoma induced by chlorthalidone. J Glaucoma. 2015
Jan;24(1):84-6. doi: 10.1097/IJG.0000000000000037. PubMed PMID: 24448565.
13: Saseen JJ, Ghushchyan V, Nair KV. Comparing clinical effectiveness and drug
toxicity with hydrochlorothiazide and chlorthalidone using two potency ratios in
a managed care population. J Clin Hypertens (Greenwich). 2015 Feb;17(2):134-40.
doi: 10.1111/jch.12453. Epub 2014 Dec 15. PubMed PMID: 25496048.
14: Wilson L, Nair KV, Saseen JJ. Comparison of new-onset gout in adults
prescribed chlorthalidone vs. hydrochlorothiazide for hypertension. J Clin
Hypertens (Greenwich). 2014 Dec;16(12):864-8. doi: 10.1111/jch.12413. Epub 2014
Sep 25. PubMed PMID: 25258088.
15: Jin C, Jeon Y, Kleven DT, Pollock JS, White JJ, Pollock DM. Combined
endothelin a blockade and chlorthalidone treatment in a rat model of metabolic
syndrome. J Pharmacol Exp Ther. 2014 Nov;351(2):467-73. doi:
10.1124/jpet.114.215566. Epub 2014 Sep 4. PubMed PMID: 25189702; PubMed Central
PMCID: PMC4201276.
16: Yamal JM, Oparil S, Davis BR, Alderman MH, Calhoun DA, Cushman WC, Fendley
HF, Franklin SS, Habib GB, Pressel SL, Probstfield JL, Sastrasinh S; ALLHAT
Collaborative Research Group. Stroke outcomes among participants randomized to
chlorthalidone, amlodipine or lisinopril in ALLHAT. J Am Soc Hypertens. 2014
Nov;8(11):808-19. doi: 10.1016/j.jash.2014.08.003. Epub 2014 Aug 19. PubMed PMID:
25455006; PubMed Central PMCID: PMC4254528.
17: Ebeid WM, Elkady EF, El-Zaher AA, El-Bagary RI, Patonay G.
Stability-indicating RP-LC method for determination of azilsartan medoxomil and
chlorthalidone in pharmaceutical dosage forms: application to degradation
kinetics. Anal Bioanal Chem. 2014 Oct;406(26):6701-12. doi:
10.1007/s00216-014-8085-0. Epub 2014 Sep 5. PubMed PMID: 25190009.
18: Baker WL, Nigro SC, White WB. Efficacy of azilsartan medoxomil with
chlorthalidone in hypertension. Expert Rev Cardiovasc Ther. 2014 Jul;12(7):791-8.
doi: 10.1586/14779072.2014.924853. Epub 2014 Jun 2. Review. PubMed PMID:
24881461.
19: van Blijderveen JC, Straus SM, Rodenburg EM, Zietse R, Stricker BH,
Sturkenboom MC, Verhamme KM. Risk of hyponatremia with diuretics: chlorthalidone
versus hydrochlorothiazide. Am J Med. 2014 Aug;127(8):763-71. doi:
10.1016/j.amjmed.2014.04.014. Epub 2014 May 5. PubMed PMID: 24811554.
20: Jin C, O'Boyle S, Kleven DT, Pollock JS, Pollock DM, White JJ.
Antihypertensive and anti-inflammatory actions of combined azilsartan and
chlorthalidone in Dahl salt-sensitive rats on a high-fat, high-salt diet. Clin
Exp Pharmacol Physiol. 2014 Aug;41(8):579-88. doi: 10.1111/1440-1681.12250.
PubMed PMID: 24798707.